Suicide vaccines against animal herpesviruses: Bovine herpesvirus type 1 as a model

Project Information

Grant agreement ID: QLK5-CT-2000-51537

Start date

End date

Funded under

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Total cost No data

EU contribution No data

Coordinated by

Universite de Liege
Belgium

Objective

Development of a novel strategy of vaccination against bovine herpesvirus 1 based on a suicide vaccine, which is able to perform only a single cycle of replication after intranasal inoculation. The vaccine combines the high immunogenic potential of a live vaccine and the safety of a killed vaccine.

Fields of science

• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › vaccines

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

Data not available

Call for proposal

Data not available

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

Universite de Liege

• EU contribution: No data
• Address: Boulevard de Colonster, 20, B43b ; 4000 Liege ; Belgium
• Total cost: No data

Participants (1)

Not available

Sweden

• EU contribution: No data
• Total cost: No data